Werewolf Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HOWL research report →
Companywerewolftx.com
Werewolf Therapeutics, Inc. , a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies.
- CEO
- Daniel J. Hicklin
- IPO
- 2021
- Employees
- 46
- HQ
- Watertown, MA, US
Price Chart
Valuation
- Market Cap
- $21.29M
- P/E
- -0.38
- P/S
- 0.00
- P/B
- 1.74
- EV/EBITDA
- -0.27
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -208.23%
- ROIC
- -103.43%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $-60,822,000 · 13.75%
- EPS
- $-1.32 · 19.02%
- Op Income
- $-60,677,000
- FCF YoY
- -6.82%
Performance & Tape
- 52W High
- $2.38
- 52W Low
- $0.40
- 50D MA
- $0.79
- 200D MA
- $1.03
- Beta
- 0.41
- Avg Volume
- 466.56K
Get TickerSpark's AI analysis on HOWL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | EVNIN LUKE | sell | 44,679 |
| May 8, 26 | EVNIN LUKE | sell | 305,741 |
| May 11, 26 | EVNIN LUKE | sell | 33,948 |
| May 12, 26 | EVNIN LUKE | sell | 67,885 |
| May 8, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 351,514 |
| May 11, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 81,678 |
| May 12, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 94,432 |
| May 8, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 25,012 |
| May 11, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 5,812 |
| May 12, 26 | RA CAPITAL MANAGEMENT, L.P. | sell | 6,719 |
Our HOWL Coverage
We haven't published any research on HOWL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HOWL Report →